Alliancebernstein L.P. Neogenomics Inc Transaction History

Alliancebernstein L.P.

$278 Billion
Q2 2024

A detailed history of Alliancebernstein L.P. transactions in Neogenomics Inc stock. As of the latest transaction made, Alliancebernstein L.P. holds 170,497 shares of NEO stock, worth $2.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

170,497

Previous 170,497 -0.0%

Holding current value

$2.47 Million

Previous $2.68 Million 11.79%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$11.67 - $20.73 $21,006 - $37,314	1,800 Added 1.07%	170,497 $2.76 Million
Q3 2023 Nov 14, 2023	SELL	$12.15 - $17.85 $676,998 - $994,602	-55,720 Reduced 24.83%	168,697 $2.07 Million
Q2 2023 Aug 15, 2023	BUY	$14.1 - $19.83 $314,994 - $443,002	22,340 Added 11.06%	224,417 $3.61 Million
Q1 2023 May 15, 2023	SELL	$9.09 - $19.45 $296,879 - $635,237	-32,660 Reduced 13.91%	202,077 $3.52 Million
Q4 2022 Feb 14, 2023	SELL	$6.45 - $12.07 $343,107 - $642,063	-53,195 Reduced 18.47%	234,737 $2.17 Million
Q3 2022 Nov 15, 2022	BUY	$7.86 - $12.91 $513,375 - $843,216	65,315 Added 29.34%	287,932 $2.48 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $13.97 $16,668 - $32,983	2,361 Added 1.07%	222,617 $1.81 Million
Q1 2022 May 13, 2022	SELL	$12.15 - $35.28 $406,903 - $1.18 Million	-33,490 Reduced 13.2%	220,256 $2.68 Million
Q4 2021 Feb 14, 2022	BUY	$30.49 - $48.49 $1.07 Million - $1.71 Million	35,188 Added 16.1%	253,746 $8.66 Million
Q3 2021 Nov 10, 2021	SELL	$41.66 - $52.52 $558,660 - $704,293	-13,410 Reduced 5.78%	218,558 $10.5 Million
Q2 2021 Jul 30, 2021	BUY	$36.62 - $51.69 $371,949 - $525,015	10,157 Added 4.58%	231,968 $10.5 Million
Q1 2021 May 06, 2021	SELL	$41.56 - $59.88 $269,308 - $388,022	-6,480 Reduced 2.84%	221,811 $10.7 Million
Q4 2020 Feb 08, 2021	BUY	$36.08 - $56.47 $1.65 Million - $2.59 Million	45,791 Added 25.09%	228,291 $12.3 Million
Q3 2020 Nov 12, 2020	SELL	$33.26 - $40.48 $105,434 - $128,321	-3,170 Reduced 1.71%	182,500 $6.73 Million
Q2 2020 Aug 13, 2020	BUY	$24.21 - $31.02 $721,942 - $925,016	29,820 Added 19.13%	185,670 $5.75 Million
Q1 2020 May 14, 2020	BUY	$20.5 - $34.53 $201,925 - $340,120	9,850 Added 6.75%	155,850 $4.3 Million
Q4 2019 Feb 18, 2020	BUY	$18.96 - $29.84 $334,644 - $526,676	17,650 Added 13.75%	146,000 $4.27 Million
Q3 2019 Nov 14, 2019	SELL	$19.12 - $26.24 $402,476 - $552,352	-21,050 Reduced 14.09%	128,350 $2.45 Million
Q2 2019 Aug 14, 2019	BUY	$19.57 - $24.1 $1.47 Million - $1.81 Million	75,100 Added 101.08%	149,400 $3.28 Million
Q1 2019 May 14, 2019	BUY	$12.14 - $20.46 $33,992 - $57,288	2,800 Added 3.92%	74,300 $1.52 Million
Q4 2018 Feb 13, 2019	BUY	$11.24 - $18.5 $11,240 - $18,500	1,000 Added 1.42%	71,500 $902,000
Q2 2018 Aug 13, 2018	BUY	$7.99 - $14.05 $23,171 - $40,745	2,900 Added 4.29%	70,500 $924,000
Q1 2018 May 14, 2018	BUY	$7.23 - $8.76 $35,427 - $42,924	4,900 Added 7.81%	67,600 $552,000
Q4 2017 Feb 13, 2018	BUY	$8.02 - $11.18 $137,944 - $192,296	17,200 Added 37.8%	62,700 $556,000
Q3 2017 Nov 13, 2017	BUY	$9.11 - $11.26 $414,505 - $512,330	45,500	45,500 $506,000

Others Institutions Holding NEO

# of Institutions

278

Shares Held

127M

Call Options Held

581K

Put Options Held

107K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.82B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Neogenomics Inc Transaction History